Mobic (Meloxicam)

Meloxicam, the active ingredient in Mobic, is a nonsteroidal anti-inflammatory drug presented as an injectable solution for intramuscular use. It treats osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute musculoskeletal pain and post‑operative pain in adult patients.

GNH USA supplies Mobic as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mobic (meloxicam) is used to manage inflammatory and painful conditions affecting the musculoskeletal system.

- Osteoarthritis: reduces joint pain and improves functional ability. - Rheumatoid arthritis: alleviates inflammation and slows joint damage progression. - Ankylosing spondylitis: decreases spinal pain and stiffness. - Acute musculoskeletal pain: provides rapid relief of pain and inflammation. - Post‑operative pain: helps control pain after surgical procedures.

Mobic may cause a range of adverse reactions, ranging from mild to serious.

Common Side Effects: - Gastrointestinal discomfort or dyspepsia - Nausea or vomiting - Diarrhea - Headache - Dizziness - Injection‑site pain or mild erythema - Transient rash

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding - Severe skin reactions such as Stevens‑Johnson syndrome - Elevated liver enzymes or hepatitis - Acute renal impairment or failure - Cardiovascular events including myocardial infarction or stroke - Anaphylaxis or severe hypersensitivity reactions

Before initiating therapy, clinicians should consider several safety aspects.

- Renal function: assess baseline kidney function and monitor during therapy. - Cardiovascular risk: use cautiously in patients with history of heart disease or hypertension. - Gastrointestinal risk: avoid in patients with active ulcer disease; consider gastroprotective agents. - Pregnancy and lactation: safety not established; avoid unless benefit outweighs risk. - Drug interactions: review concomitant NSAIDs, anticoagulants, and ACE inhibitors. - Store at ambient temperature: keep in original container, protect from moisture and light.

Meloxicam can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal and renal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): heightened bleeding risk. - ACE inhibitors or ARBs: may reduce renal function. - Lithium: increased serum lithium levels.

Moderate Interactions (Monitor Closely): - Diuretics: may enhance nephrotoxic potential. - Methotrexate: possible increased toxicity. - Cyclosporine: heightened renal risk.